- Home
- products
- asia middle east
- drug development
Show results for
Refine by
Drug Development Equipment Supplied In Asia Middle East
42 equipment items found
by:KoBioLabs based inGwanak-ro, Gwanak-gu, SOUTH KOREA
New Drug Development Focusing on Immune/Metabolic/Neurological. ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Agonist refers to substances that activate a specific target protein. It can easily be viewed as the opposite of inhibitor. Until now, Deargen's drug-target interaction (DTI) was predicted based on the binding affinity between the substance and the target protein, which causes barrier to distinguish between the inhibition and activation activity. In addition, the demand for ...
Manufactured by:Hunan Aslsen Technology Co., Ltd based inFurong District, CHINA
Name: BMK Glycidic Acid CAS 5449-12-7 Purity: 99% Type: Pharmaceutical Intermediates Appearance: White Powder Function: Pharmaceutical Intermediates: BMK Ethyl Glycidate is commonly used as an intermediate in drug synthesis for the preparation of precursors or active ingredients of some drugs. In the pharmaceutical field, organic synthesis intermediates are ...
Manufactured by:Hunan Aslsen Technology Co., Ltd based inFurong District, CHINA
Name: BMK Ethyl Glycidate CAS 41232-97-7 Purity: 99% Type: Pharmaceutical Intermediates Appearance: Yellow Liquid; White Powder Function: Pharmaceutical Intermediates: BMK Ethyl Glycidate is commonly used as an intermediate in drug synthesis for the preparation of precursors or active ingredients of some drugs. In the pharmaceutical field, organic synthesis ...
Manufactured by:Troikaa Pharmaceuticals Ltd. based inAhmedabad, INDIA
To provide therapeutically meaningful extended delivery of drugs, Troikaa has developed Duo Phase Technology. Through this technology, the drug dose is split judiciously into two components, where one part delivers the drug immediately and the other releases the drug in a sustained release pattern. Thus ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
PROTAC is composed of a protein of interest, a ligand that binds to the E3 ligase, and a linker that connects the two. PROTAC is emerging as a next-generation platform for new drug development that overcomes the problems of drug resistance and “Undruggable targets” of existing target therapies whose main purpose was to inhibit the ...
by:ImageProVision Technology Pvt. Ltd. based inPune, INDIA
This system improves the accuracy and efficiency of microscopic particle characterization, making it particularly useful in pharmaceutical applications such as new drug development, FDA approval processes, and ANDA filings. The software is user-friendly, flexible, and interactive, simplifying complex analysis tasks for professionals in the ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC is committed to creating solutions for longstanding challenges in drug development by enabling new therapies with entirely unique properties. TLC has proprietary solution for pharmaceutical product development called LipAD®. LipAD® allows the design of medicines at the nanometer scale, improving drug solubility, ...
Manufactured by:DX Fluidics based inSuzhou, CHINA
They utilize precise microstructures to manipulate and observe cells at a microscopic scale. Applications include drug screening, disease modeling, and tissue engineering. Various types are used in research, such as lung and heart tissue chips, which mimic organ structures and functions, providing insights into physiological and pathological processes. Microfluidic PEEK chips and ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
MolEQ designs novel compounds by optimizing multiple properties such as efficacy and toxicity of a lead ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
To hinder or inhibit the function of proteins that cause disease, many pharmaceutical companies develop drugs called inhibitors. Each of the 20,000 proteins in the human body has its own unique functions. Depending on the function of the protein, it can be classified into enzyme proteins, ion channel proteins, transport proteins, defense proteins, and structural ...
Manufactured by:SHL Medical AG based inZug, SWITZERLAND
The development of the Precision Pen Injector (PPI) is a story of uncompromising dedication to meeting industry challenges. A Swedish company specializing in solutions for aesthetics and corrective treatment sought to introduce an autoinjector for its skin booster – a highly viscous hyaluronic acid formulation of several hundred centipoise. The company needed a device that could deliver ...
Manufactured by:Suvoda based inConshohocken, PENNSYLVANIA (USA)
Full visibility and automated control. Extend your clinical trial command and control center with Suvoda’s integrated ...
by:Theramx Inc. based inSeongnam-si, SOUTH KOREA
Drug delivery platform technology designed to maximize efficacy while simultaneously minimizing side effects of existing drugs by delivery to desired ...
Manufactured by:MitoImmune Therapeutics Inc. based inGangnam-gu, SOUTH KOREA
The blood-brain barrier (BBB) penetrating technology is essential to develop drugs for neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, ALS, and Huntington’s disease, which have high unmet medical needs. MitoImmune has developed BIM Technology, a central nervous system target technology, and is conducting R&D ...
Manufactured by:Nissan Chemical Corporation based inTokyo, JAPAN
This is an antihypercholesterolemic agent characteristic of having a strong LDL cholesterol reduction effect and causing less drug-interactions. It is recognized as one of the “Strong statins” in clinical practice. In Japan, it is distributed by Kowa Company, Limited. It has been launched in 30 countries, such as the United States and countries in Latin America, ...
Manufactured by:Nanjing Deda New Materials Technology Co., Ltd. based inNanjing, CHINA
PMK ethyl glycidate is an important intermediate in pharmaceutical synthesis, particularly in the production of certain chemicals used in research and development. While PMK ethyl glycidate has legitimate industrial uses, it is crucial to emphasize that its use should comply with all applicable laws and regulations. Research and Development: PMK ethyl glycidate ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
DearDTI presents drug candidates with a good efficacy by predicting the binding affinity, based on information about the compound-protein ...
Manufactured by:Mimetas B.V. based inLeiden, NETHERLANDS
OrganoServices are available for multiple assays to allow compound profiling and/or screening in human-relevant, complex 3D tissue models. When developing new drugs, it is critical to understand the permeability, absorption, and transport mechanisms in relevant biological systems. An important prerequisite to study this is the epithelial barrier function. To ...
Manufactured by:SEQENS Group based inÉcully, FRANCE
Our Drug Delivery Solutions Business Unit coordinates our Custom Lipids activity. Seqens strongly believes in the potential of new cutting-edge technologies. In the pharmaceutical industry, lipids and polymers are core excipients in the development of drug delivery systems. ...